Timonium, Maryland
United States
34
2023-06-29
The entities that hold a legal rights for patent applications filed by inventor Hung Chien-Fu:
Chien-Fu Hung from Timonium, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITIONS COMPRISING ANNEXIN V AND HPV TUMOR ANTIGEN FUSION POLYPEPTIDES AND METHODS FOR MAKING AND USE
#2 | 2022-07-07COMPOSITIONS COMPRISING ALBUMIN-FMS-LIKE TYROSINE KINASE 3 LIGAND FUSION PROTEINS AND USES THEREOF
#3 | 2020-12-17Methods for enhancing antigen-specific immune responses
#4 | 2020-11-12ANTI-CANCER DNA VACCINE EMPLOYING PLASMIDS ENCODING SIGNAL SEQUENCE, MUTANT ONCOPROTEIN ANTIGEN, AND HEAT SHOCK PROTEIN
#5 | 2020-03-26Mesothelin vaccines and model systems
#6 | 2019-10-10NON-INVASIVE CANCER DETECTION AND ANALYSIS BY SINGLE-MOLECULE IMAGING
#7 | 2019-07-11Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof
#8 | 2018-06-21Methods for enhancing antigen-specific immune responses
#9 | 2018-05-24Anti-Cancer DNA Vaccine Employing Plasmids Encoding Signal Sequence, Mutant Oncoprotein Antigen, and Heat Shock Protein
#10 | 2018-02-08Compositions and methods for enhancing an immune response
#11 | 2017-05-18Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#12 | 2017-03-16Mesothelin vaccines and model systems
#13 | 2016-11-03Methods of Treatment of HPV Related Diseases
#14 | 2015-08-20Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#15 | 2015-07-02COMPOSITIONS AND METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
#16 | 2014-02-20Mesothelin vaccines and model systems
#17 | 2013-08-08Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen
#18 | 2013-05-16Tumor Cell-Based Cancer Immunotherapeutic Compositions and Methods
#19 | 2012-10-18Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
#20 | 2012-09-27Compositions and Methods for Enhancing Antigen-Specific Immune Responses
#21 | 2012-09-06METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
#22 | 2012-03-29Mesothelin vaccines and model systems
#23 | 2010-12-30Anticancer Combination Therapies
#24 | 2010-11-04Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
#25 | 2009-11-19Tumor cell-based cancer immunotherapeutic compositions and methods
#26 | 2009-06-11Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
#27 | 2009-04-30Mesothelin Vaccines and Model Systems and Control of Tumors
#28 | 2009-04-09DNA vaccine enhancement with MHC class II activators
#29 | 2008-11-20MOLECULAR VACCINE LINKING INTERCELLULAR SPREADING PROTEIN TO AN ANTIGEN
#30 | 2008-10-23HPV DNA Vaccines and Methods of Use Thereof
#31 | 2008-05-01Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin
#32 | 2008-03-20RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
#33 | 2007-02-01Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins
#34 | 2005-08-11Mesothelin vaccines and model systems
246714 ⎘